# CS481 Team 1 — Week 9 Data Quality Audit

**Week:** 9 (October 12–18, 2026)  
**Responsible:** Ifeanyi — Team Leader  
**Project:** Zero-Width Unicode Steganography with Social-Media Robustness Engineering

## 1. Purpose

The purpose of this audit is to ensure that production trial data is complete, accurate, consistent, and suitable for statistical analysis.

The Week 9 milestone is to complete at least 50% of the planned production data collection.

## 2. Data Validation Checklist

Each production trial will be reviewed for the following:

- [ ] Platform name is recorded.
- [ ] Test number or unique trial identifier is recorded.
- [ ] Original message or approved test-case reference is recorded.
- [ ] Number of zero-width characters sent is recorded.
- [ ] Number of zero-width characters recovered is recorded.
- [ ] Number of codec characters removed or added is recorded.
- [ ] Count-based character retention is calculated correctly.
- [ ] Exact-match decoding success or failure is recorded.
- [ ] Platform behavior and anomalies are documented.
- [ ] Duplicate records are identified.
- [ ] Missing fields and impossible values are flagged.
- [ ] Manual transcription errors are checked against original evidence.

## 3. Validation Rules

- Character counts must be nonnegative integers.
- The number of recovered characters cannot exceed the number sent without an explanation of inserted or duplicated characters.
- Count-based character retention = (retrieved codec-character total / sent
  codec-character total) × 100.
- Count-based retention does not prove that the retrieved characters match the
  original sequence. Substitutions, insertions, and ordering changes require
  separate decoder and exact-match results.
- Exact-match recovery must be recorded separately from character survival.
- Any unexpected result must be documented for further review.
- Zero-length encoded trials require separate handling because the survival-rate denominator would be zero.

## 4. Compatibility Matrix Audit

The following platforms were identified in the original testing requirements:

| Platform | Week 9 Production Trials | Validation Status | Notes |
|---|---|---|---|
| WeChat | Pending | Not reviewed | |
| Telegram | Pending | Not reviewed | |
| Gmail | Pending | Not reviewed | |
| Microsoft Word | Pending | Not reviewed | |
| Notepad++ | Pending | Not reviewed | |
| Browser Console | Pending | Not reviewed | |
| Microsoft Outlook | Pending | Not reviewed | |
| Discord | Pending | Not reviewed | |

The final matrix will be updated using Tristan's actual production data. Previous prototype results will remain separate from the Week 9 production dataset.

## 5. Audit Findings

**Records reviewed:** Pending  
**Missing or incomplete records:** Pending  
**Duplicate records:** Pending  
**Invalid values:** Pending  
**Unexplained anomalies:** Pending

No Week 9 production dataset has been audited at the time this document was created.

## 6. Team Coordination

**Tristan:** Provide production trial logs, supporting evidence, and preliminary statistics.

**Henry:** Investigate codec-related anomalies and verify decoding behavior on recovered sequences.

**Ifeanyi:** Audit trial records, document data-quality findings, and maintain the compatibility matrix.

## 7. Week 9 Progress

**Target:** At least 50% of planned production trials completed.

**Current verified progress:** Pending review of production trial logs.

**Next Action:** Review Tristan's first production data batch and record validation findings.

## 8. Methodology Review and Production Data Requirements

**Review Date:** October 12, 2026  
**Reviewed By:** Ifeanyi  
**Reference:** [Tristan's Week 8 Testing Methodology](tristan_week8_testing_methodology_section.md)
### Previous Testing Methodology

The team previously evaluated platform compatibility and recovery performance under controlled corruption conditions.

Testing recorded zero-width characters sent and recovered, character survival rates, decoding outcomes, and platform behavior.

### Data Quality Improvements for Week 9

The following requirements will be checked during the production data audit:

- [ ] Record the platform and application/browser version.
- [ ] Record the exact operation performed during each trial.
- [ ] Use a unique identifier for each trial.
- [ ] Record the test message or approved corpus reference.
- [ ] Verify character counts and survival-rate calculations.
- [ ] Record exact-match decoding success separately from survival rate.
- [ ] Document decoder errors and unexpected platform behavior.
- [ ] Preserve supporting evidence for each trial.
- [ ] Check for missing fields, duplicate trials, and inconsistent results.
- [ ] Confirm that the approved frozen protocol was followed.

### Production Dataset Verification

**Frozen testing protocol:** Awaiting confirmation of the approved Week 9 version.

**Balanced test corpus:** Awaiting confirmation of the approved corpus and its test-case distribution.

**Total planned production trials:** Pending.

**Completed production trials:** Pending verification.

**Week 9 milestone:** At least 50% of the planned production dataset completed.

**Milestone verification status:** Not yet verified. Completion percentage will be calculated after the approved trial count and validated production logs are available.

### Audit Status

The Week 8 testing methodology has been reviewed to identify required measurements and previous documentation limitations.

The Week 9 production dataset has not yet been independently validated. Audit findings and completion percentages will be updated after Tristan provides the production trial logs.

## 9. Week 9 Leadership Decision and Audit Update

**Decision Date:** October 17, 2026
**Authorized By:** Ifeanyi Emeka, Team Leader
**Reference:** docs/week9_testing_protocol_draft.md

Following the team meeting, the team leader authorized
the Week 9 production testing scope to prevent delays
in project progress and assignment submission.

### Approved Testing Scope

- Eight platform-operation combinations.
- Eight approved corpus messages per combination.
- Three trials per message.
- Total planned trials: 192.
- Week 9 target: 96 completed trials (50%).
- Browser Console: paste-and-copy-back only.

### Verification Status

- Henry's codec verification: Complete.
- Automated regression: 33 tests and 132 subtests passed.
- Local corpus verification: 8 of 8 passed.
- Exact platform-operation matrix: Pending documentation.
- Tristan's production trial logs: Pending review.
- Production data-quality audit: Pending trial records.

### Audit Conclusion

The revised production testing scope has been authorized by the team leader. However, the protocol is not fully frozen until the seven approved platform-operation combinations and their exact workflows are documented and verified.

No unverified production trials are counted as
completed. The 50% milestone remains a target
until supporting trial records are reviewed.

All future findings will be supported by recorded
measurements, decoding results, and evidence.

### Revised Production Testing Scope

**Decision:** The team leader approved a revised production testing scope following the Week 9 team meeting.

**Approved platform-operation combinations:** 7

**Test corpus:** 8 approved messages

**Repetitions per message:** 3

**Total planned production trials:** 168 (7 × 8 × 3)

**Week 9 milestone:** Complete at least 50% of the planned production trials (84 trials).

**WeChat status:** Excluded from the current production scope pending access verification.

**Protocol reference:** `docs/week9_testing_protocol_draft.md`, Section 11.

### Verification Status

The revised testing scope has been authorized by the team leader. Final platform workflows and assignments still require verification before production testing begins.

No production trials are reported as completed without supporting trial logs and evidence.

The audit will be updated once Tristan provides the production testing records.